Cogitai: Newormics, Cogitai and Opticlean Pitch at UT Austin's Startup Studio

By LAURA LOREK Reporter with Silicon Hills News Pharmaceutical researchers have file cabinets filled with information on potential drugs that have not yet been thoroughly tested. A cure for Parkinson's disease, ALS, or Amyotrophic Lateral Sclerosis or Alzheimer's disease, may be in one of those files. Those untested drug compounds linger because the process from [...]The post Newormics, Cogitai and Opticlean Pitch at UT Austin's Startup Studio appeared first on SiliconHills.